Diabetes 52:214-217, 2003
© 2003 by the American Diabetes Association, Inc.
Variation in Resistin Gene Promoter Not Associated With Polycystic Ovary Syndrome
Margrit Urbanek1,
Yangzhu Du1,
Kaisa Silander2,
Francis S. Collins2,
Claire M. Steppan3,
Jerome F. Strauss, III4,
Andrea Dunaif5,
Richard S. Spielman1, and
Richard S. Legro6
1 Department of Genetics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
2 Genome Technology Branch, National Human Genome Research Institute, Bethesda, Maryland
3 Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
4 Center for Research on Reproduction and Womens Health and Department of Obstetrics and Gynecology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
5 Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Medical School, Chicago, Illinois
6 Department of Obstetrics and Gynecology, College of Medicine, Pennsylvania State University, Hershey, Pennsylvania
Polycystic ovary syndrome (PCOS) is a leading cause of anovulatory infertility and affects 47% of reproductive age women in the U.S. It is characterized by hyperandrogenemia and chronic anovulation and is associated with insulin resistance, obesity, and increased risk for type 2 diabetes. In a screen of candidate genes, a region on chromosome 19p13.3 was identified that shows significant evidence for both linkage and association with PCOS. A promising candidate gene for PCOS, resistin, maps to exactly this region. Resistin is a protein hormone thought to modulate glucose tolerance and insulin action. We tested for association between a single nucleotide polymorphism in the promoter region of the resistin gene and three phenotypes: PCOS, obesity, and insulin resistance. We did not find evidence for association with any of the phenotypes. It is therefore unlikely that variation in the resistin gene accounts for the strong association that we observe between chromosome 19p13.3 and PCOS. Instead, this association is most likely due to a gene or genetic element in this region that has not been identified.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Simoni, C.B. Tempfer, B. Destenaves, and B.C.J.M. Fauser
Functional genetic polymorphisms and female reproductive disorders: Part I: polycystic ovary syndrome and ovarian response
Hum. Reprod. Update,
September 1, 2008;
14(5):
459 - 484.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Urbanek, S. Sam, R. S. Legro, and A. Dunaif
Identification of a Polycystic Ovary Syndrome Susceptibility Variant in Fibrillin-3 and Association with a Metabolic Phenotype
J. Clin. Endocrinol. Metab.,
November 1, 2007;
92(11):
4191 - 4198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.R. Jones, S.G. Wilson, B.H. Mullin, R. Mead, G.F. Watts, and B.G.A. Stuckey
Polymorphism of the follistatin gene in polycystic ovary syndrome
Mol. Hum. Reprod.,
April 1, 2007;
13(4):
237 - 241.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. G. Gosman, H. I. Katcher, and R. S. Legro
Obesity and the role of gut and adipose hormones in female reproduction
Hum. Reprod. Update,
September 1, 2006;
12(5):
585 - 601.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.F. Escobar-Morreale, G. Villuendas, J.I. Botella-Carretero, F. Alvarez-Blasco, R. Sanchon, M. Luque-Ramirez, and J.L. San Millan
Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study
Hum. Reprod.,
September 1, 2006;
21(9):
2257 - 2265.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Qin, D. A. Ehrmann, N. Cox, S. Refetoff, and R. L. Rosenfield
Identification of a Functional Polymorphism of the Human Type 5 17{beta}-Hydroxysteroid Dehydrogenase Gene Associated with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab.,
January 1, 2006;
91(1):
270 - 276.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Urbanek, A. Woodroffe, K. G. Ewens, E. Diamanti-Kandarakis, R. S. Legro, J. F. Strauss III, A. Dunaif, and R. S. Spielman
Candidate Gene Region for Polycystic Ovary Syndrome on Chromosome 19p13.2
J. Clin. Endocrinol. Metab.,
December 1, 2005;
90(12):
6623 - 6629.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Diamanti-Kandarakis and C. Piperi
Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth
Hum. Reprod. Update,
November 1, 2005;
11(6):
631 - 643.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. F. Escobar-Morreale, M. Luque-Ramirez, and J. L. San Millan
The Molecular-Genetic Basis of Functional Hyperandrogenism and the Polycystic Ovary Syndrome
Endocr. Rev.,
April 1, 2005;
26(2):
251 - 282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Wickenheisser, V. L. Nelson-DeGrave, and J. M. McAllister
Dysregulation of Cytochrome P450 17{alpha}-Hydroxylase Messenger Ribonucleic Acid Stability in Theca Cells Isolated from Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab.,
March 1, 2005;
90(3):
1720 - 1727.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Diabetes Association.
|
|
| |
|